Cardiovascular Actions of the Dopamine Receptor Agonist Z1046 in Swine

By Duncker Dirk   van Meegen Johan   Verdouw Pieter  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 4, 1997-09 ,pp. : 537-545

Springer Publishing Company

Access to resources Recommend Favorite

Effect of YM435, a Dopamine DA 1 Receptor Agonist, in a Canine Model of Ischemic Acute Renal Failure - an update of dopamine and a first look at dobutamine

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 803-807

Elsevier

Access to resources Recommend Favorite

Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: a microdialysis study

By Wang J.   Yang X.   Camporesi C.V.   Yang Z.-j.   Bosco G.   Chen C.   Camporesi E.M.  

European Journal of Pharmacology, Vol. 452, Iss. 3, 2002-10 ,pp. : 303-308

Elsevier

Access to resources Recommend Favorite

Dopamine DA 1 Receptor Agonist Activity of YM435 in the Canine Renal Vasculature

By Yatsu T.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Monophosphoryl lipid A reduces both arrhythmia severity and infarct size in a rat model of ischaemia

By Song W.   Furman B.L.   Parratt J.R.  

European Journal of Pharmacology, Vol. 345, Iss. 3, 1998-03 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite